Financhill
Buy
59

WAT Quote, Financials, Valuation and Earnings

Last price:
$372.88
Seasonality move :
8.36%
Day range:
$367.16 - $373.55
52-week range:
$279.24 - $397.02
Dividend yield:
0%
P/E ratio:
35.61x
P/S ratio:
7.63x
P/B ratio:
13.82x
Volume:
105.4K
Avg. volume:
536.3K
1-year change:
13.16%
Market cap:
$22.2B
Revenue:
$3B
EPS (TTM):
$10.48

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
WAT
Waters
$713.2M $2.68 4.53% 10.57% $381.54
CTSO
CytoSorbents
$10.2M -$0.06 28.63% -41.38% --
DCTH
Delcath Systems
$10.5M -$0.19 2204.21% -93.94% --
EXAS
Exact Sciences
$717M -$0.10 8.59% -18.18% $71.86
PGNY
Progyny
$297.4M $0.37 2.66% 183.52% $30.22
STRR
Star Equity Holdings
$13.2M -$0.32 21.89% -605.27% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
WAT
Waters
$373.15 $381.54 $22.2B 35.61x $0.00 0% 7.63x
CTSO
CytoSorbents
$0.89 -- $49.1M -- $0.00 0% 1.39x
DCTH
Delcath Systems
$11.34 -- $362.6M -- $0.00 0% 13.59x
EXAS
Exact Sciences
$58.11 $71.86 $10.8B -- $0.00 0% 3.95x
PGNY
Progyny
$14.53 $30.22 $1.2B 25.05x $0.00 0% 1.26x
STRR
Star Equity Holdings
$2.08 -- $6.7M 0.70x $0.00 0% 0.13x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
WAT
Waters
53.25% 2.197 8.55% 1.23x
CTSO
CytoSorbents
51.51% 0.791 16.8% 1.46x
DCTH
Delcath Systems
18.92% 0.853 0.79% 0.97x
EXAS
Exact Sciences
44.45% -0.061 20.38% 1.78x
PGNY
Progyny
-- 1.563 -- 2.48x
STRR
Star Equity Holdings
15.99% -0.852 31.89% 1.35x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
WAT
Waters
$438.7M $212.5M 18.23% 49.2% 29.05% $179M
CTSO
CytoSorbents
$4.5M -$4.4M -70.49% -103.21% -20.27% -$2.8M
DCTH
Delcath Systems
$9.6M -$1.3M -167.55% -251.36% -11.24% -$3.9M
EXAS
Exact Sciences
$512.6M -$20.8M -3.82% -6.77% -4.11% $112.6M
PGNY
Progyny
$59.2M $12.5M 11.31% 11.31% 4.35% $42.7M
STRR
Star Equity Holdings
$2.8M -$5.3M -9.23% -10.13% -38.95% $420K

Waters vs. Competitors

  • Which has Higher Returns WAT or CTSO?

    CytoSorbents has a net margin of 21.82% compared to Waters's net margin of -27.1%. Waters's return on equity of 49.2% beat CytoSorbents's return on equity of -103.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    59.25% $2.71 $3.4B
    CTSO
    CytoSorbents
    52.3% -$0.04 $26.8M
  • What do Analysts Say About WAT or CTSO?

    Waters has a consensus price target of $381.54, signalling upside risk potential of 2.25%. On the other hand CytoSorbents has an analysts' consensus of -- which suggests that it could grow by 459.79%. Given that CytoSorbents has higher upside potential than Waters, analysts believe CytoSorbents is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    3 16 0
    CTSO
    CytoSorbents
    0 0 0
  • Is WAT or CTSO More Risky?

    Waters has a beta of 1.007, which suggesting that the stock is 0.67699999999999% more volatile than S&P 500. In comparison CytoSorbents has a beta of 0.568, suggesting its less volatile than the S&P 500 by 43.192%.

  • Which is a Better Dividend Stock WAT or CTSO?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters pays -- of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WAT or CTSO?

    Waters quarterly revenues are $740.3M, which are larger than CytoSorbents quarterly revenues of $8.6M. Waters's net income of $161.5M is higher than CytoSorbents's net income of -$2.3M. Notably, Waters's price-to-earnings ratio is 35.61x while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 7.63x versus 1.39x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    7.63x 35.61x $740.3M $161.5M
    CTSO
    CytoSorbents
    1.39x -- $8.6M -$2.3M
  • Which has Higher Returns WAT or DCTH?

    Delcath Systems has a net margin of 21.82% compared to Waters's net margin of 16.64%. Waters's return on equity of 49.2% beat Delcath Systems's return on equity of -251.36%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    59.25% $2.71 $3.4B
    DCTH
    Delcath Systems
    85.36% $0.06 $10.6M
  • What do Analysts Say About WAT or DCTH?

    Waters has a consensus price target of $381.54, signalling upside risk potential of 2.25%. On the other hand Delcath Systems has an analysts' consensus of -- which suggests that it could grow by 88.13%. Given that Delcath Systems has higher upside potential than Waters, analysts believe Delcath Systems is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    3 16 0
    DCTH
    Delcath Systems
    0 0 0
  • Is WAT or DCTH More Risky?

    Waters has a beta of 1.007, which suggesting that the stock is 0.67699999999999% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.851, suggesting its less volatile than the S&P 500 by 14.882%.

  • Which is a Better Dividend Stock WAT or DCTH?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WAT or DCTH?

    Waters quarterly revenues are $740.3M, which are larger than Delcath Systems quarterly revenues of $11.2M. Waters's net income of $161.5M is higher than Delcath Systems's net income of $1.9M. Notably, Waters's price-to-earnings ratio is 35.61x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 7.63x versus 13.59x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    7.63x 35.61x $740.3M $161.5M
    DCTH
    Delcath Systems
    13.59x -- $11.2M $1.9M
  • Which has Higher Returns WAT or EXAS?

    Exact Sciences has a net margin of 21.82% compared to Waters's net margin of -5.4%. Waters's return on equity of 49.2% beat Exact Sciences's return on equity of -6.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    59.25% $2.71 $3.4B
    EXAS
    Exact Sciences
    72.33% -$0.21 $5.8B
  • What do Analysts Say About WAT or EXAS?

    Waters has a consensus price target of $381.54, signalling upside risk potential of 2.25%. On the other hand Exact Sciences has an analysts' consensus of $71.86 which suggests that it could grow by 23.66%. Given that Exact Sciences has higher upside potential than Waters, analysts believe Exact Sciences is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    3 16 0
    EXAS
    Exact Sciences
    17 3 0
  • Is WAT or EXAS More Risky?

    Waters has a beta of 1.007, which suggesting that the stock is 0.67699999999999% more volatile than S&P 500. In comparison Exact Sciences has a beta of 1.237, suggesting its more volatile than the S&P 500 by 23.719%.

  • Which is a Better Dividend Stock WAT or EXAS?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WAT or EXAS?

    Waters quarterly revenues are $740.3M, which are larger than Exact Sciences quarterly revenues of $708.7M. Waters's net income of $161.5M is higher than Exact Sciences's net income of -$38.2M. Notably, Waters's price-to-earnings ratio is 35.61x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 7.63x versus 3.95x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    7.63x 35.61x $740.3M $161.5M
    EXAS
    Exact Sciences
    3.95x -- $708.7M -$38.2M
  • Which has Higher Returns WAT or PGNY?

    Progyny has a net margin of 21.82% compared to Waters's net margin of 3.64%. Waters's return on equity of 49.2% beat Progyny's return on equity of 11.31%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    59.25% $2.71 $3.4B
    PGNY
    Progyny
    20.67% $0.11 $434.9M
  • What do Analysts Say About WAT or PGNY?

    Waters has a consensus price target of $381.54, signalling upside risk potential of 2.25%. On the other hand Progyny has an analysts' consensus of $30.22 which suggests that it could grow by 29.78%. Given that Progyny has higher upside potential than Waters, analysts believe Progyny is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    3 16 0
    PGNY
    Progyny
    4 4 0
  • Is WAT or PGNY More Risky?

    Waters has a beta of 1.007, which suggesting that the stock is 0.67699999999999% more volatile than S&P 500. In comparison Progyny has a beta of 1.350, suggesting its more volatile than the S&P 500 by 34.952%.

  • Which is a Better Dividend Stock WAT or PGNY?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WAT or PGNY?

    Waters quarterly revenues are $740.3M, which are larger than Progyny quarterly revenues of $286.6M. Waters's net income of $161.5M is higher than Progyny's net income of $10.4M. Notably, Waters's price-to-earnings ratio is 35.61x while Progyny's PE ratio is 25.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 7.63x versus 1.26x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    7.63x 35.61x $740.3M $161.5M
    PGNY
    Progyny
    1.26x 25.05x $286.6M $10.4M
  • Which has Higher Returns WAT or STRR?

    Star Equity Holdings has a net margin of 21.82% compared to Waters's net margin of -14.42%. Waters's return on equity of 49.2% beat Star Equity Holdings's return on equity of -10.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    WAT
    Waters
    59.25% $2.71 $3.4B
    STRR
    Star Equity Holdings
    20.62% -$0.78 $69.5M
  • What do Analysts Say About WAT or STRR?

    Waters has a consensus price target of $381.54, signalling upside risk potential of 2.25%. On the other hand Star Equity Holdings has an analysts' consensus of -- which suggests that it could grow by 380.77%. Given that Star Equity Holdings has higher upside potential than Waters, analysts believe Star Equity Holdings is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    WAT
    Waters
    3 16 0
    STRR
    Star Equity Holdings
    0 0 0
  • Is WAT or STRR More Risky?

    Waters has a beta of 1.007, which suggesting that the stock is 0.67699999999999% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.080, suggesting its less volatile than the S&P 500 by 91.951%.

  • Which is a Better Dividend Stock WAT or STRR?

    Waters has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Waters pays -- of its earnings as a dividend. Star Equity Holdings pays out 7.62% of its earnings as a dividend. Star Equity Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios WAT or STRR?

    Waters quarterly revenues are $740.3M, which are larger than Star Equity Holdings quarterly revenues of $13.7M. Waters's net income of $161.5M is higher than Star Equity Holdings's net income of -$2M. Notably, Waters's price-to-earnings ratio is 35.61x while Star Equity Holdings's PE ratio is 0.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Waters is 7.63x versus 0.13x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WAT
    Waters
    7.63x 35.61x $740.3M $161.5M
    STRR
    Star Equity Holdings
    0.13x 0.70x $13.7M -$2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is The Santa Claus Rally The Gift That Keeps Giving?
Is The Santa Claus Rally The Gift That Keeps Giving?

Remember the horror of 2008 when the Great Recession hit…

Is Alphabet an Undervalued Growth Stock to Buy?
Is Alphabet an Undervalued Growth Stock to Buy?

Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 118x

Buy
58
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
87
PSIX alert for Dec 25

Power Solutions International [PSIX] is up 27.42% over the past day.

Buy
65
TSLL alert for Dec 25

Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.

Buy
75
SMLR alert for Dec 25

Semler Scientific [SMLR] is up 15.37% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock